Cite
HARVARD Citation
Xu, S. et al. (2021). Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021). Advanced science. 8 (5), p. n/a. [Online].